- Investopedia•20 days ago
Analysts initiate coverage on new companies for a variety of reasons. This analyst sees a 259% upside for this biopharmaceutical stock.
- Business Wire•27 days ago
CANCER RESEARCH UK has today announced its first cross-company deal as part of its Experimental Cancer Medicine Centre Combinations Alliance.
- Business Wire•2 months ago
Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced that the company will present at the Rodman & Renshaw 18th Annual Global Investment Conference on Tuesday, September 13th at 10:25 AM Eastern Time at The Lotte New York Palace Hotel.
Verastem, Inc. (VSTM)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Day's Range||1.22 - 1.30|
|52wk Range||1.05 - 2.43|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-1.03|
|Avg Vol (3m)||231,246|
|Dividend & Yield||N/A (N/A)|